LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 5 of total 5

Search options

  1. Article ; Online: IL-33 and ST2 as predictors of disease severity in children with viral acute lower respiratory infection.

    Portugal, Carolina Augusta Arantes / de Araújo Castro, Ítalo / Prates, Mirela Cristina Moreira / Gagliardi, Talita Bianca / Martins, Ronaldo Bragança / de Jesus, Bruna Laís Santos / de Souza Cardoso, Ricardo / da Silva, Marcus Vinícius Gomes / Aragon, Davi Casale / Arruda Neto, Eurico / Alves Filho, José Carlos Farias / Cunha, Fernando de Queiroz / Carlotti, Ana Paula de Carvalho Panzeri

    Cytokine

    2020  Volume 127, Page(s) 154965

    Abstract: Background: Mechanisms influencing severity of acute lower respiratory infection (ALRI) in children are not established. We aimed to assess the role of inflammatory markers and respiratory viruses in ALRI severity.: Methods: Concentrations of ... ...

    Abstract Background: Mechanisms influencing severity of acute lower respiratory infection (ALRI) in children are not established. We aimed to assess the role of inflammatory markers and respiratory viruses in ALRI severity.
    Methods: Concentrations of interleukin(IL)-33, soluble suppression of tumorigenicity (sST)2, IL-1ß, tumor necrosis factor α, IL-4, IL-6 and IL- 8 and types of respiratory viruses were evaluated in children at the first and fifth days after hospital admission. Disease severity was defined as need for mechanical ventilation.
    Results: Seventy-nine children <5 years-old were included; 33(41.8%) received mechanical ventilation. No associations between virus type, viral load or co-detections and severity of disease were observed. Detection of IL-33 and sST2 in nasopharyngeal aspirates (NPA) on admission were associated with higher risk for mechanical ventilation (RR = 2.89 and RR = 4.57, respectively). IL-6 and IL-8 concentrations were higher on Day 5 in mechanically ventilated children. IL-6 NPA concentrations decreased from Day 1 to Day 5 in children who did not receive mechanical ventilation. Increase in sST2 NPA concentrations from Day 1 to Day 5 was associated with longer hospital length of stay (p < 0.01).
    Conclusions: An exacerbated local activation of the IL-33/ST2 axis and persistently high sST2 concentrations over time were associated with severity of viral ALRI in children.
    MeSH term(s) Biomarkers/metabolism ; Child, Preschool ; Female ; Hospitalization ; Humans ; Interleukin-1 Receptor-Like 1 Protein/metabolism ; Interleukin-33/metabolism ; Interleukin-6/metabolism ; Interleukin-8/metabolism ; Male ; Prospective Studies ; Respiratory Syncytial Virus Infections/metabolism ; Respiratory Syncytial Virus Infections/pathology ; Respiratory Tract Infections/metabolism ; Respiratory Tract Infections/pathology ; Severity of Illness Index
    Chemical Substances Biomarkers ; IL1RL1 protein, human ; IL33 protein, human ; Interleukin-1 Receptor-Like 1 Protein ; Interleukin-33 ; Interleukin-6 ; Interleukin-8
    Keywords covid19
    Language English
    Publishing date 2020-01-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1018055-2
    ISSN 1096-0023 ; 1043-4666
    ISSN (online) 1096-0023
    ISSN 1043-4666
    DOI 10.1016/j.cyto.2019.154965
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Clinical Trial of Efficacy and Toxicity of Disoproxil Tenofovir Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections

    Lima, Aldo A M / Arruda, Erico A G / Pires-Neto, Roberto J / Medeiros, Melissa S / Quirino-Filho, J / Clementino, Marco A / Gondim, Rafhaella N D G / Magalhaes, Lyvia M C / Cavalcante, Kerene F / Viana, Vania A F / Perdigao, Liana / Magalhaes, Pedro J C / Santos, Armenio A / Martins, R B / Havt, Alexandre / Lopes, N P / Arruda-Neto, Eurico

    medRxiv

    Abstract: This study aimed to evaluate the efficacy and toxicity of tenofovir (TDF) and TDF combined with emtricitabine (TDF/FTC) in patients with mild to moderate COVID-19 infections. We conducted a randomized, double-blind, placebo-controlled clinical trial in ... ...

    Abstract This study aimed to evaluate the efficacy and toxicity of tenofovir (TDF) and TDF combined with emtricitabine (TDF/FTC) in patients with mild to moderate COVID-19 infections. We conducted a randomized, double-blind, placebo-controlled clinical trial in patients with clinical suspicion of mild to moderate respiratory infection caused by SARS-CoV-2 who were treated at an outpatient clinic. Patients were randomly recruited to take 10 days of TDF (300 mg/day), TDF (300 mg/day) combined with FTC (200 mg/day) or placebo Vitamin C (500 mg/day). The primary parameter was the score of symptoms and predictive signs of COVID-19, assessed on the seventh day of patient follow-up. From a total of 309 patients with clinical suspicion of SARS-CoV-2, 227 met the inclusion criteria and were randomly distributed into the following groups: (a) 75 (one did not initiate treatment) in the TDF group; (b) 74 in the TDF combined with FTC group; and (c) 77 in the Vitamin C group (placebo). Of the 226 patients, 139 (62%) were positive for SARS-CoV-2. Fever (37.8oC), ageusia or dysgeusia, anosmia or dysosmia, and two or more clinical symptoms or signs were significantly associated with SARS-CoV-2 infection. There was no significant change in clinical score based on clinical symptoms and signs between treatment groups. Patients with mild to moderate infection by SARS-CoV-2 had higher concentrations of G-CSF, IL-1β, IL-6 and TNF-α compared to patients without infection. Patients with mild to moderate respiratory infection, with fever (37.8oC), loss of smell, loss of taste and two or more symptoms, have a better prediction for the diagnosis of COVID-19. Patients with SARS-CoV-2 showed higher and more persistent proinflammatory cytokines profile compared to patients not infected with SARS-CoV-2. Pharmacological intervention with TDF or TDF combined with FTC did not change the clinical signs and symptoms score in mild to moderate respiratory infection in patients with SARS-CoV-2 compared to the Vitamin C group (placebo).
    Keywords covid19
    Language English
    Publishing date 2021-09-30
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.09.28.21264242
    Database COVID19

    Kategorien

  3. Article ; Online: Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells.

    Salina, Ana C G / Dos-Santos, Douglas / Rodrigues, Tamara S / Fortes-Rocha, Marlon / Freitas-Filho, Edismauro G / Alzamora-Terrel, Daniel L / Castro, Icaro M S / Fraga da Silva, Thais F C / de Lima, Mikhael H F / Nascimento, Daniele C / Silva, Camila M / Toller-Kawahisa, Juliana E / Becerra, Amanda / Oliveira, Samuel / Caetité, Diego B / Almeida, Leticia / Ishimoto, Adriene Y / Lima, Thais M / Martins, Ronaldo B /
    Veras, Flavio / do Amaral, Natália B / Giannini, Marcela C / Bonjorno, Letícia P / Lopes, Maria I F / Benatti, Maira N / Batah, Sabrina S / Santana, Rodrigo C / Vilar, Fernando C / Martins, Maria A / Assad, Rodrigo L / de Almeida, Sergio C L / de Oliveira, Fabiola R / Arruda Neto, Eurico / Cunha, Thiago M / Alves-Filho, José C / Bonato, Vania L D / Cunha, Fernando Q / Fabro, Alexandre T / Nakaya, Helder I / Zamboni, Dario S / Louzada-Junior, Paulo / Oliveira, Rene D R / Cunha, Larissa D

    eLife

    2022  Volume 11

    Abstract: COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering immunopathogenesis are not established. The functional plasticity of macrophages allows this cell type to promote pathogen elimination and inflammation or suppress ... ...

    Abstract COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering immunopathogenesis are not established. The functional plasticity of macrophages allows this cell type to promote pathogen elimination and inflammation or suppress inflammation and promote tissue remodeling and injury repair. During an infection, the clearance of dead and dying cells, a process named efferocytosis, can modulate the interplay between these contrasting functions. Here, we show that engulfment of SARS-CoV-2-infected apoptotic cells exacerbates inflammatory cytokine production, inhibits the expression of efferocytic receptors, and impairs continual efferocytosis by macrophages. We also provide evidence supporting that lung monocytes and macrophages from severe COVID-19 patients have compromised efferocytic capacity. Our findings reveal that dysfunctional efferocytosis of SARS-CoV-2-infected cell corpses suppresses macrophage anti-inflammation and efficient tissue repair programs and provides mechanistic insights for the excessive production of pro-inflammatory cytokines and accumulation of tissue damage associated with COVID-19 immunopathogenesis.
    MeSH term(s) Anti-Inflammatory Agents/pharmacology ; Apoptosis ; COVID-19 ; Humans ; Macrophages/metabolism ; Phagocytosis ; SARS-CoV-2
    Chemical Substances Anti-Inflammatory Agents
    Language English
    Publishing date 2022-06-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.74443
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory programming and continual clearance of apoptotic cells

    dos-Santos, Douglas / Salina, Ana C. G. / Rodrigues, Tamara S. / Rocha, Marlon F. / Freitas-Filho, Edismauro G. / Alzamora-Terrel, Daniel L. / de Lima, Mikhael H. F. / Nascimento, Daniele B. C. / Castro, Icaro / Silva, Camila M. / Toller-Kawahisa, Juliana E. / Becerra, Amanda / Oliveira, Samuel / Caetite, Diego B. / Almeida, Leticia / Ishimoto, Adriene Y. / Lima, Thais M. / Martins, Ronaldo B. / Veras, Flavio /
    do Amaral, Natalia B. / Giannini, Marcela C. / Bonjorno, Leticia P. / Lopes, Maria I. F. / Benatti, Maira N. / Batah, Sabrina S. / Santana, Rodrigo C. / Vilar, Fernando C. / Martins, Maria A. / Assad, Rodrigo L. / de Almeida, Sergio C. L. / de Oliveira, Fabiola R. / Arruda Neto, Eurico / Cunha, Thiago M. / Alves-Filho, Jose C / Cunha, Fernando Q. / Fabro, Alexandre T. / Nakaya, Helder I / Zamboni, Dario S. / Louzada-Junior, Paulo / Oliveira, Rene D. R. / Cunha, Larissa D.

    medRxiv

    Abstract: COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering immunopathogenesis are not established. The functional plasticity of macrophages allows this cell type to promote pathogen elimination and inflammation or suppress ... ...

    Abstract COVID-19 is a disease of dysfunctional immune responses, but the mechanisms triggering immunopathogenesis are not established. The functional plasticity of macrophages allows this cell type to promote pathogen elimination and inflammation or suppress inflammation and promote tissue remodeling and injury repair. During an infection, the clearance of dead and dying cells, a process named efferocytosis, can modulate the interplay between these contrasting functions. Here, we show that engulfment of SARS-CoV2-infected apoptotic cells (AC) exacerbates inflammatory cytokine production, inhibits the expression of efferocytic receptors, and impairs continual efferocytosis by macrophages. We also provide evidence that monocytes from severe COVID-19 patients express reduced levels of efferocytic receptors and fail to uptake AC. Our findings reveal that dysfunctional efferocytosis of SARS-CoV-2-infected cell corpses suppress macrophage anti-inflammation and efficient tissue repair programs and provide mechanistic insights for the pathogenesis of the hyperinflammation and extensive tissue damage associated with COVID-19.
    Keywords covid19
    Language English
    Publishing date 2021-02-23
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2021.02.18.21251504
    Database COVID19

    Kategorien

  5. Article ; Online: SARS-CoV-2 infects brain astrocytes of COVID-19 patients and impairs neuronal viability

    Crunfli, Fernanda / Corasolla Carregari, Victor / Veras, Flavio Protasio / Vendramini, Pedro Henrique / Valenca, Aline Gazzola Fragnani / Antunes, Andre Saraiva Leao Marcelo / Brandao-Teles, Carolina / Zuccoli, Giuliana da Silva / Reis-de-Oliveira, Guilherme / Silva-Costa, Licia C. / Saia-Cereda, Verônica Monteiro / Codo, Ana Campos / Parise, Pierina Lorencini / Toledo-Teixeira, Daniel A. / de Souza, Gabriela Fabiano / Muraro, Stéfanie Primon / Melo, Bruno Marcel Silva / Almeida, Glaucia M. / Firmino, Egidi Mayara Silva /
    Ludwig, Raíssa Guimarães / Palermo Ruiz, Gabriel / Knittel, Thiago Leite / Davanzo, Gustavo Gastão / Gerhardt, Jaqueline Aline / Rodrigues, Patrícia Brito / Forato, Julia / Amorim, Mariene Ribeiro / Brunetti Silva, Natália / Martini, Matheus Cavalheiro / Benatti, Maíra Nilson / Batah, Sabrina / Siyuan, Li / Pereira Silva, Rafael Elias Marques / João, Rafael Batista / Scardua Silva, Lucas / Nogueira, Mateus Henrique / Karmann Aventurato, ítalo / Rabelo de Brito, Mariana / Machado Alvim, Marina Koutsodontis / da Silva Junior, José Roberto / Damião, Lívia Liviane / Castilho Stefano, Maria Ercilia de Paula / Pereira de Sousa, Iêda Maria / Dias da Rocha, Elessandra / Gonçalves, Solange Maria / Lopes da Silva, Luiz Henrique / Bettini, Vanessa / Machado de Campos, Brunno / Ludwig, Guilherme / Mendes Viana, Rosa Maria / Martins, Ronaldo / Vieira, Andre S. / Alves-Filho, José Carlos / de Arruda Neto, Eurico / Sebollela, Adriano / Cendes, Fernando / Cunha, Fernando Q / Damásio, André / Vinolo, Marco Aurélio Ramirez / Munhoz, Carolina Demarchi / Rehen, Stevens K / Mauad, Thais / Duarte-Neto, Amaro Nunes / Ferraz da Silva, Luiz Fernando / Dolhnikoff, Marisa / Saldiva, Paulo / Todorovic Fabro, Alexandre / Farias, Alessandro S / Moraes-Vieira, Pedro Manoel M. / Proença Módena, José Luiz / Lin Yasuda, Clarissa / Mori, Marcelo A. / Cunha, Thiago Mattar / Martins-de-Souza, Daniel

    medRxiv

    Abstract: COVID-19 patients may exhibit neuropsychiatric and/or neurological symptoms. We found that anxiety and cognitive impairment are manifested by 28-56% of SARS-CoV-2-infected individuals with mild or no respiratory symptoms and are associated with altered ... ...

    Abstract COVID-19 patients may exhibit neuropsychiatric and/or neurological symptoms. We found that anxiety and cognitive impairment are manifested by 28-56% of SARS-CoV-2-infected individuals with mild or no respiratory symptoms and are associated with altered cerebral cortical thickness. Using an independent cohort, we found histopathological signs of brain damage in 19% of individuals who died of COVID-19. All of the affected brain tissues exhibited foci of SARS-CoV-2 infection, particularly in astrocytes. Infection of neural stem cell-derived astrocytes changed energy metabolism, altered key proteins and metabolites used to fuel neurons and for biogenesis of neurotransmitters, and elicited a secretory phenotype that reduces neuronal viability. Our data support the model where SARS-CoV-2 reaches the brain, infects astrocytes and triggers neuropathological changes that contribute to the structural and functional alterations in the brain of COVID-19 patients.
    Keywords covid19
    Language English
    Publishing date 2020-10-13
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.10.09.20207464
    Database COVID19

    Kategorien

To top